Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 356, Issue 5, 1997, Pages 583-589

  Schlicker, E ^a   Timm, J ^a   Zentner, J ^b   Gothert M ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

cAMP accumulation; Cannabinoid CB1 receptors; Guinea pig hippocampus; Human hippocampus; Noradrenaline release; Presynaptic receptors; SR 141716; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CYCLIC AMP; NORADRENALIN; PRESYNAPTIC RECEPTOR; RIMONABANT; DRUG RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GUINEA PIG; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; RAT; ANIMAL; BRAIN; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ELECTROSTIMULATION; FEMALE; MALE; METABOLISM; SPECIES DIFFERENCE; WISTAR RAT;

ANIMALS; BRAIN; CYCLIC AMP; ELECTRIC STIMULATION; FEMALE; GUINEA PIGS; HUMANS; MALE; MICE; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SPECIES SPECIFICITY;

EID: 0030608801     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005093     Document Type: Article

References (23)

1. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
2. Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613
3. Devane WA, Hanuš L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949
4. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691
5. Gifford AN, Ashby CR (1996) Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist. SR141716A. J Pharmacol Exp Ther 277:1431-1436
6. Gifford AN, Samiian L, Gatley SJ, Ashby CR (1997) Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices. Eur J Pharmacol 324:187-192
7. 3H]-(-)-noradrenaline from the isolated vas deferens of the rat. Br J Pharmacol 52:233-236
8. Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634
9. 1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118:2023-2028
10. 1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Naunyn-Schmiedeberg's Arch Pharmacol 356:197-202
11. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564
12. Mechoulam R, Hanuš L, Martin B (1994) Search for endogenous ligands of the cannabinoid receptor. Biochem Pharmacol 48:1537-1544
13. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65
14. 1 receptors in mouse urinary bladder. Br J Pharmacol 118:2053-2058
15. Pertwee RG, Fernando SR, Griffin G, Abadji V, Makriyannis A (1995) Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur J Pharmacol 272:73-78
16. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G (1994) SR141716, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244
17. Rinaldi-Carmona M, Barth F, Héaulme M, Alonso R, Shire D, Congy C, Soubrié P, Brelière JC, Le Fur G (1995) Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56:1941-1947
18. 3 receptors on the noradrenergic terminals in the mouse brain. Neuroscience 79:247-254
19. Schlicker E, Timm J, Göthert M (1996) Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedeberg's Arch Pharmacol 354:791-795
20. Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334
21. Sim LJ, Selley DE, Xiao R, Childers SR (1996) Differences in G-protein activation by μ- and δ-opioid, and Cannabinoid, receptors in rat striatum. Eur J Pharmacol 307:97-105
22. Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1-124
23. Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69:864-989